3.0.0 2510 2026-01-15T04:53:17Z 2026-01-15T04:53:17Z Senate S S 2023-07-26 118 https://www.congress.gov/bill/118th-congress/senate-bill/2510 sshr00 Health, Education, Labor, and Pensions Committee Senate Standing Referred To 2023-07-26T17:06:52Z 118 6802 HR 2023-12-15 Referred to the Subcommittee on Health. Identical bill CRS 2023-07-26 sshr00 Health, Education, Labor, and Pensions Committee Senate Read twice and referred to the Committee on Health, Education, Labor, and Pensions. IntroReferral 2023-07-26 Introduced in Senate IntroReferral 10000 9 Library of Congress P000595 Sen. Peters, Gary C. [D-MI] Gary Peters D MI N B000944 Sen. Brown, Sherrod [D-OH] Sherrod Brown D OH 2023-07-26 True B001243 Sen. Blackburn, Marsha [R-TN] Marsha Blackburn R TN 2023-07-26 True B001305 Sen. Budd, Ted [R-NC] Ted Budd R NC 2023-10-04 False W000800 Sen. Welch, Peter [D-VT] Peter Welch D VT 2023-10-19 False E000295 Sen. Ernst, Joni [R-IA] Joni Ernst R IA 2023-10-19 False Health Congressional oversight 2024-06-05T20:26:50Z Drug safety, medical device, and laboratory regulation 2024-06-05T20:26:50Z Government information and archives 2024-06-05T20:26:50Z Government studies and investigations 2024-06-05T20:26:50Z Manufacturing 2024-06-05T20:26:50Z Prescription drugs 2024-06-05T20:26:50Z Public contracts and procurement 2024-06-05T20:26:50Z Strategic materials and reserves 2024-06-05T20:26:50Z Health 2023-09-11T18:00:42Z

00 2023-07-26 Introduced in Senate 2024-10-10T22:00:16Z <p><strong>Rolling Active Pharmaceutical Ingredient and Drug Reserve Act or the RAPID Reserve Act</strong></p><p>This bill requires the Department of Health and Human Services to contract with drug manufacturers to ensure adequate supplies of critical drugs that have vulnerable supply chains. (Under the bill, drugs are considered critical if they are likely to be needed during a public health emergency or if a shortage would pose a significant threat to the health care system or at-risk populations.)</p><p>Contracted drug manufacturers must agree to (1) maintain at least a 6-month reserve of the active ingredient in a critical drug and of the finished product and to regularly replenish these reserves, (2) produce the ingredient and drug in a manner and quantity as specified in the contract, and (3) agree to transfer portions of the reserve, if necessary, to other manufacturers to meet manufacturing needs and allow HHS to control the allocation of reserves in the event of a public health emergency or other threat.</p><p>HHS must publish a list of critical drugs and issue guidance on the criteria for determining this list and awarding contracts. HHS must give preference to domestic manufacturers for contracts.&nbsp;</p><p>In addition, the Government Accountability Office must report on the capacity of domestic manufacturing with respect to critical drugs, including the ability to manufacture different dosage forms and drugs with various characteristics.</p>

Display Title 45 2024-07-24T15:20:50Z Short Title(s) as Introduced 101 2024-05-24T13:37:29Z Introduced in Senate IS Short Title(s) as Introduced 101 2024-05-24T13:37:29Z Introduced in Senate IS Official Title as Introduced 6 2023-08-16T02:59:17Z Introduced in Senate IS Introduced in Senate 2023-07-26T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-118s2510is/xml/BILLS-118s2510is.xml 2023-07-26 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.